RE:RE:PFE to acquire Seagen?Another advantage with the acquisition of ONCY is that Big Pharma, like Merck, Pfizer and Roche, would not face FTC and EU Competition Board secrutiny, as had Merck when they attempted to acquire Seagen last year for US$40 Billion.